Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 May;93(5):1047-1048.
doi: 10.1002/ana.26637. Epub 2023 Mar 21.

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific

Affiliations
Comment

Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific

Jung-Min Pyun et al. Ann Neurol. 2023 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest

Nothing to report.

Figures

FIGURE:
FIGURE:
GAP43 gene expression levels in bulk brain tissue and cell-type specific gene expression. A−/T− (n = 181) is a group with negative amyloidopathy and negative tauopathy, A+/T− (n = 106) is a group with positive amyloidopathy but negative tauopathy, and A+/T+ (n = 296) is a group with positive amyloidopathy and positive tauopathy. The boxplots describe the median (horizontal bar), interquartile range (IQR; hinges), and 1.5 × IQR (whiskers). Each point represents a separate individual. The dashed horizontal line in A represents the median value of the A−/T− group. *p < 0.05, ***p < 0.001.

Comment in

Comment on

References

    1. Lan G, Cai Y, Li A, et al. Association of presynaptic loss with Alzheimer’s disease and cognitive decline. Ann Neurol. 2022;92:1001–1015. 10.1002/ana.26492. - DOI - PubMed
    1. Wang J, Roeder K, Devlin B. Bayesian estimation of cell type-specific gene expression with prior derived from single-cell data. Genome Res 2021;31:1807–1818. - PMC - PubMed
    1. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 1991;41:479–486. - PubMed
    1. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389–404. - PMC - PubMed
    1. Holahan MR. A shift from a pivotal to supporting role for the growth-associated protein (GAP-43) in the coordination of axonal structural and functional plasticity. Front Cell Neurosci 2017;11:266. 10.3389/fncel.2017.00266. - DOI - PMC - PubMed